Similarly, silencing of retinoic acid-inducible gene 1 (RIG1) by using a selective agonist encapsulated in lipid calcium phosphate (LCP) nanoparticles (NPs) enhanced the anti-tumor effect by silencing BCL2, which enhanced apoptosis 60. This evidence concerns the gene BCL2 and neoplasm.